Drug Type Monoclonal antibody |
Synonyms IMTNN |
Target- |
Mechanism ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), Immunomodulators, T lymphocytes stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization iOmx Therapeutics AGStartup |
Active Organization iOmx Therapeutics AGStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | DE | iOmx Therapeutics AGStartup | - |